Penumbra, Inc. (PEN) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Penumbra, Inc. · Health Care · ref. ETF XLV · 103 calls · price $321
What the company does: Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.
📈 Penumbra, Inc. (PEN) stock price
$321+18.2% over range
Aug 28, 25low $225.54 · high $359.4Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 3 analysts
📊 JPI status : Penumbra, Inc. is no longer in our current JPI rankings, but appeared in the past (2021) — its upside may be behind it. See the stocks picked in 2021 →
🎯 PEN price target & analyst consensus — price $321
The price target · all analysts combined (3 targets)
Highest target · 1 firm of 3$374+16.5%
Median target · of 3 targets$350+9.0%
Lowest target · 1 firm of 3$320-0.3%
Current price$321
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: RBC Capital — 57% of its targets hit on this sector (195 calls tested). It aims for $374 (+17 %), call made on June 12, 2026, maturing on June 12, 2027 (77 d ago).
The 1 reliable analyst
$374+17 %
The 2 other firms
$335+4.4 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $374 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy133%
Hold267%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 PEN price target all
All 103 calls, one by one, with our verdict on each firm.
→ See all 103 targets, analyst by analyst💡 The best analysts on PEN most reliable
Their real reliability on PEN, firm by firm: who was right, who was wrong.
→ See their reliability on PENAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Penumbra, Inc.? The JPI assistant answers using our backtest data.
📈 Penumbra, Inc. fundamentals: valuation, margins & growth › open the full page
P/E 79.5Net margin 10.7 %Revenue growth +14.9 %Very expensive vs its growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -0 %
2023
Rev +25%
2024
Rev +13%Profit −85%
2025
Rev +17%Profit +1168%
🔎 Detailed analyses
✅ Historical analyst reliability on PEN
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| B of A Securities ↗ | 100% | +49.0% | 2 |
| BMO Capital ↗ | 100% | +32.9% | 2 |
| Stifel ↗ | 100% | +20.6% | 2 |
| UBS ↗ | 100% | +20.6% | 4 |
| Canaccord Genuity ↗ | 90% | +26.9% | 20 |
| Deutsche Bank ↗ | 75% | +30.4% | 4 |
| JP Morgan ↗ | 75% | +22.9% | 8 |
| Wells Fargo ↗ | 75% | +18.1% | 16 |
| Baird ↗ | 75% | +13.5% | 8 |
| Truist Securities ↗ | 70% | +11.4% | 23 |
See the other 5 firms
| RBC Capital ↗ | 62% | +15.7% | 13 |
| Citigroup ↗ | 64% | +18.0% | 14 |
| Needham ↗ | 67% | +18.3% | 3 |
| Piper Sandler ↗ | 69% | +8.6% | 13 |
| BTIG ↗ | 69% | +12.9% | 16 |
📊 What $1,000 invested in Penumbra, Inc. would be worth › open the full page
In short — $1,000 invested in Penumbra, Inc. 10 years ago would be worth $5,868 today, i.e. +19%/yr on average. Best year: 2021 (+64%), worst: 2022 (-23%). Price performance, excluding dividends.
If I'd invested $1,000 in Penumbra, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,330 | +33% |
| 3 years ago | $1,419 | +42% |
| 5 years ago | $1,804 | +80% |
Return by year (Penumbra, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +2% | $1,016 (+2%) |
| 2025 | +31% | $1,330 (+33%) |
| 2024 | -6% | $1,255 (+26%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Penumbra, Inc.
Loading news…
📋 All analyst calls on PEN
Filtered on — · ✕ show all
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$320
Price at call : $318.31 — upside +1%
Today : $321 — upside -0%
🎯 on PEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
RBC Capital ↗
Jun 11, 26
■ Sector Perform neutral · not a buy · 🎯$374
Price at call : $318.71 — gap to target +17%
Today : $321 — gap to target +17%
🎯 on PEN : 100% (3 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
■ Neutral neutral · not a buy · 🎯$350
Price at call : $322.23 — gap to target +9%
Today : $321 — gap to target +9%
🎯 on PEN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Evercore ISI Group ↗
May 7, 26
▲ Outperform · 🎯$335
Price at call : $322.23 — upside +4%
Today : $321 — upside +4%
🎯 on PEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Evercore ISI Group ↗
Feb 26, 26
▲ Outperform · 🎯$360
Price at call : $344.39 — upside +5%
Today : $321 — upside +12%
🎯 on PEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
RBC Capital ↗
Jan 20, 26
■ Sector Perform neutral · not a buy · 🎯$374
Price at call : $357.68 — gap to target +5%
Today : $321 — gap to target +17%
🎯 on PEN : 100% (3 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
Canaccord Genuity ↗
Jan 20, 26
■ Hold neutral · not a buy · 🎯$374
Price at call : $355.44 — gap to target +5%
Today : $321 — gap to target +17%
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
■ Hold neutral · not a buy · 🎯$374
Price at call : $355.44 — gap to target +5%
Today : $321 — gap to target +17%
🎯 on PEN : no call matured yet · 📊 on Health : 49.1% · +10.3% (112 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
See the other 95 calls, newest to oldest
■ Hold neutral · not a buy
🎯 on PEN : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
■ Neutral neutral · not a buy · 🎯$374
Price at call : $350.78 — gap to target +7%
Today : $321 — gap to target +17%
🎯 on PEN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
Leerink Partners ↗
Jan 16, 26
■ Market Perform neutral · not a buy · 🎯$374
Price at call : $350.78 — gap to target +7%
Today : $321 — gap to target +17%
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
■ Neutral neutral · not a buy · 🎯$374
Price at call : $350.78 — gap to target +7%
Today : $321 — gap to target +17%
🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
■ Neutral neutral · not a buy · 🎯$349
Price at call : $350.78 — gap to target -1%
Today : $321 — gap to target +9%
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
Truist Securities ↗
Jan 16, 26
■ Hold neutral · not a buy · 🎯$374
Price at call : $350.78 — gap to target +7%
Today : $321 — gap to target +17%
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
Wells Fargo ↗
Jan 15, 26
■ Equal-Weight neutral · not a buy · 🎯$374
Price at call : $350.78 — gap to target +7%
Today : $321 — gap to target +17%
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jan 15, 27
matures : Jan 15, 27
William Blair ↗
Jan 15, 26
■ Market Perform neutral · not a buy
🎯 on PEN : no call matured yet · 📊 on Health : 50% · +37.8% (20 calls)
in progress (365j)
matures : Jan 15, 27
matures : Jan 15, 27
B of A Securities ↗
Jan 5, 26
▲ Buy · 🎯$370
Price at call : $315 — upside +17%
Today : $321 — upside +15%
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Truist Securities ↗
Dec 18, 25
▲ Buy · 🎯$370
Price at call : $315.9 — upside +17%
Today : $321 — upside +15%
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
▲ Overweight · 🎯$370
Price at call : $315.35 — upside +17%
Today : $321 — upside +15%
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
Canaccord Genuity ↗
Dec 17, 25
▲ Buy · 🎯$359
Price at call : $315.35 — upside +14%
Today : $321 — upside +12%
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Buy · 🎯$388
Price at call : $309.26 — upside +25%
Today : $321 — upside +21%
🎯 on PEN : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Buy · 🎯$350
Price at call : $311.4 — upside +12%
Today : $321 — upside +9%
🎯 on PEN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
■ Neutral neutral · not a buy · 🎯$275
Price at call : $266.19 — gap to target +3%
Today : $321 — gap to target -14%
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Canaccord Genuity ↗
Nov 6, 25
▲ Buy · 🎯$355
Price at call : $266.19 — upside +33%
Today : $321 — upside +11%
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$326
Price at call : $247.99 — upside +31%
Today : $321 — upside +2%
🎯 on PEN : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
▲ Buy · 🎯$320
Price at call : $247.99 — upside +29%
Today : $321 — upside -0%
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
Truist Securities ↗
Oct 15, 25
▲ Buy · 🎯$300
Price at call : $253.84 — upside +18%
Today : $321 — upside -7%
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
▲ Buy · 🎯$326
Price at call : $258.95 — upside +26%
Today : $321 — upside +2%
🎯 on PEN : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$285
Price at call : $258.95 — upside +10%
Today : $321 — upside -11%
🎯 on PEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
Evercore ISI Group ↗
Sep 2, 25
▲ Outperform · 🎯$300
Price at call : $269.5 — upside +11%
Today : $321 — upside -7%
🎯 on PEN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Sep 2, 26
matures : Sep 2, 26
Morgan Stanley ↗
Jul 31, 25
■ Equal-Weight neutral · not a buy · 🎯$266
Price at call : $243.01 — gap to target +9%
Today : $321 — gap to target -17%
🎯 on PEN : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Jul 31, 26
matures : Jul 31, 26
Truist Securities ↗
Jul 30, 25
▲ Buy · 🎯$310
Price at call : $252.27 — upside +23%
Today : $321 — upside -3%
Expected +23% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+27.3%
stock +27% · XLV +25%
matured Jul 30, 26
▲ Buy · 🎯$335
Price at call : $252.27 — upside +33%
Today : $321 — upside +4%
Expected +33% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+27.3%
stock +27% · XLV +25%
matured Jul 30, 26
RBC Capital ↗
Jul 30, 25
▲ Outperform · 🎯$325
Price at call : $252.27 — upside +29%
Today : $321 — upside +1%
Expected +29% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 100% (3 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+27.3%
stock +27% · XLV +25%
matured Jul 30, 26
▲ Outperform · 🎯$285
Price at call : $252.27 — upside +13%
Today : $321 — upside -11%
Expected +13% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.7% · +1.8% (76 calls)
+27.3%
stock +27% · XLV +25%
matured Jul 30, 26
Wells Fargo ↗
Jul 30, 25
▲ Overweight · 🎯$290
Price at call : $252.27 — upside +15%
Today : $321 — upside -10%
Expected +15% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+27.3%
stock +27% · XLV +25%
matured Jul 30, 26
Canaccord Genuity ↗
Jul 30, 25
▲ Buy · 🎯$350
Price at call : $254.21 — upside +38%
Today : $321 — upside +9%
Expected +38% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+25.8%
stock +26% · XLV +22%
matured Jul 30, 26
■ Neutral neutral · not a buy · 🎯$285
Price at call : $243.87 — gap to target +17%
Today : $321 — gap to target -11%
🎯 on PEN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Jul 9, 26
matures : Jul 9, 26
RBC Capital ↗
Apr 24, 25
▲ Outperform · 🎯$330
Price at call : $299.78 — upside +10%
Today : $321 — upside +3%
Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 100% (3 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+9.4%
stock +9% · XLV +4%
matured Apr 24, 26
▲ Buy · 🎯$330
Price at call : $299.78 — upside +10%
Today : $321 — upside +3%
Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+9.4%
stock +9% · XLV +4%
matured Apr 24, 26
Truist Securities ↗
Apr 24, 25
▲ Buy · 🎯$330
Price at call : $299.78 — upside +10%
Today : $321 — upside +3%
Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+9.4%
stock +9% · XLV +4%
matured Apr 24, 26
▲ Buy · 🎯$318
Price at call : $299.78 — upside +6%
Today : $321 — upside -1%
Expected +6% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 48% · +12.4% (98 calls)
+9.4%
stock +9% · XLV +4%
matured Apr 24, 26
Wells Fargo ↗
Apr 24, 25
▲ Overweight · 🎯$315
Price at call : $298.25 — upside +6%
Today : $321 — upside -2%
Expected +6% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+10.6%
stock +11% · XLV +5%
matured Apr 24, 26
▲ Outperform · 🎯$325
Price at call : $298.25 — upside +9%
Today : $321 — upside +1%
Expected +9% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 100% (2 calls matureds) · 📊 on Health : 48.7% · +1.8% (76 calls)
+10.6%
stock +11% · XLV +5%
matured Apr 24, 26
Truist Securities ↗
Apr 11, 25
▲ Buy · 🎯$315
Price at call : $270.27 — upside +17%
Today : $321 — upside -2%
Expected +17% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+22.7%
stock +23% · XLV +7%
matured Apr 11, 26
B of A Securities ↗
Mar 14, 25
▲ Buy · 🎯$320
Price at call : $272.62 — upside +17%
Today : $321 — upside -0%
Expected +17% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 64.8% · +20.2% (105 calls)
+23.3%
stock +23% · XLV +4%
matured Mar 14, 26
▲ Overweight · 🎯$285
Price at call : $303.12 — upside -6%
Today : $321 — upside -11%
Expected -6% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 49.3% · +6.2% (142 calls)
+12.0%
stock +12% · XLV +7%
matured Feb 19, 26
Truist Securities ↗
Feb 19, 25
▲ Buy · 🎯$325
Price at call : $303.12 — upside +7%
Today : $321 — upside +1%
Expected +7% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+12.0%
stock +12% · XLV +7%
matured Feb 19, 26
RBC Capital ↗
Feb 19, 25
▲ Outperform · 🎯$313
Price at call : $303.12 — upside +3%
Today : $321 — upside -2%
Expected +3% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 100% (3 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+12.0%
stock +12% · XLV +7%
matured Feb 19, 26
Canaccord Genuity ↗
Feb 19, 25
▲ Buy · 🎯$340
Price at call : $303.12 — upside +12%
Today : $321 — upside +6%
Expected +12% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+12.0%
stock +12% · XLV +7%
matured Feb 19, 26
Wells Fargo ↗
Feb 19, 25
▲ Overweight · 🎯$305
Price at call : $303.76 — upside +0%
Today : $321 — upside -5%
Expected +0% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+12.2%
stock +12% · XLV +7%
matured Feb 19, 26
Piper Sandler ↗
Feb 19, 25
▲ Overweight · 🎯$330
Price at call : $303.76 — upside +9%
Today : $321 — upside +3%
Expected +9% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+12.2%
stock +12% · XLV +7%
matured Feb 19, 26
Truist Securities ↗
Dec 18, 24
▲ Buy · 🎯$285
Price at call : $243.52 — upside +17%
Today : $321 — upside -11%
Expected +17% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+29.7%
stock +30% · XLV +14%
matured Dec 18, 25
Wells Fargo ↗
Dec 11, 24
▲ Overweight · 🎯$275
Price at call : $253.66 — upside +8%
Today : $321 — upside -14%
Expected +8% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+22.8%
stock +23% · XLV +8%
matured Dec 11, 25
Canaccord Genuity ↗
Dec 9, 24
▲ Buy · 🎯$323
Price at call : $242.27 — upside +33%
Today : $321 — upside +1%
Expected +33% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+25.1%
stock +25% · XLV +6%
matured Dec 9, 25
▲ Buy · 🎯$270
Price at call : $244.15 — upside +11%
Today : $321 — upside -16%
Expected +11% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+20.1%
stock +20% · XLV +7%
matured Nov 26, 25
Piper Sandler ↗
Nov 20, 24
▲ Overweight · 🎯$250
Price at call : $240.49 — upside +4%
Today : $321 — upside -22%
Expected +4% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+20.0%
stock +20% · XLV +7%
matured Nov 20, 25
Canaccord Genuity ↗
Nov 4, 24
▲ Buy · 🎯$260
Price at call : $229.51 — upside +13%
Today : $321 — upside -19%
Expected +13% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+2.4%
stock +2% · XLV -1%
matured Nov 4, 25
Piper Sandler ↗
Oct 31, 24
▲ Overweight · 🎯$235
Price at call : $233.3 — upside +1%
Today : $321 — upside -27%
Expected +1% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-3.0%
stock -3% · XLV -2%
matured Oct 31, 25
▲ Buy · 🎯$232
Price at call : $228.87 — upside +1%
Today : $321 — upside -28%
Expected +1% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-0.7%
stock -1% · XLV -2%
matured Oct 31, 25
Truist Securities ↗
Oct 31, 24
▲ Buy · 🎯$240
Price at call : $228.87 — upside +5%
Today : $321 — upside -25%
Expected +5% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-0.7%
stock -1% · XLV -2%
matured Oct 31, 25
Piper Sandler ↗
Oct 18, 24
▲ Overweight · 🎯$225
Price at call : $206.68 — upside +9%
Today : $321 — upside -30%
Expected +9% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+19.8%
stock +20% · XLV -4%
matured Oct 18, 25
Canaccord Genuity ↗
Oct 16, 24
▲ Buy · 🎯$235
Price at call : $202.26 — upside +16%
Today : $321 — upside -27%
Expected +16% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+23.1%
stock +23% · XLV -6%
matured Oct 16, 25
▲ Buy · 🎯$234
Price at call : $206.62 — upside +13%
Today : $321 — upside -27%
Expected +13% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+22.3%
stock +22% · XLV -7%
matured Oct 14, 25
Truist Securities ↗
Oct 14, 24
▲ Buy · 🎯$235
Price at call : $206.62 — upside +14%
Today : $321 — upside -27%
Expected +14% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+22.3%
stock +22% · XLV -7%
matured Oct 14, 25
Leerink Partners ↗
Sep 3, 24
▲ Outperform · 🎯$263
Price at call : $204.97 — upside +28%
Today : $321 — upside -18%
Expected +28% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
+31.6%
stock +32% · XLV -13%
matured Sep 3, 25
▲ Buy · 🎯$224
Price at call : $202.4 — upside +11%
Today : $321 — upside -30%
Expected +11% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+34.7%
stock +35% · XLV -12%
matured Aug 28, 25
▲ Buy · 🎯$187
Price at call : $171.25 — upside +9%
Today : $321 — upside -42%
Expected +9% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+41.9%
stock +42% · XLV -13%
matured Jul 31, 25
Truist Securities ↗
Jul 31, 24
▲ Buy · 🎯$200
Price at call : $171.25 — upside +17%
Today : $321 — upside -38%
Expected +17% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+41.9%
stock +42% · XLV -13%
matured Jul 31, 25
Canaccord Genuity ↗
Jul 31, 24
▲ Buy · 🎯$176
Price at call : $167.09 — upside +5%
Today : $321 — upside -45%
Expected +5% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+51.0%
stock +51% · XLV -13%
matured Jul 31, 25
Piper Sandler ↗
Jul 31, 24
▲ Overweight · 🎯$200
Price at call : $167.09 — upside +20%
Today : $321 — upside -38%
Expected +20% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+51.0%
stock +51% · XLV -13%
matured Jul 31, 25
Truist Securities ↗
Jul 16, 24
▲ Buy · 🎯$230
Price at call : $203.22 — upside +13%
Today : $321 — upside -28%
Expected +13% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+13.2%
stock +13% · XLV -12%
matured Jul 16, 25
▲ Buy · 🎯$232
Price at call : $196.75 — upside +18%
Today : $321 — upside -28%
Expected +18% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+19.1%
stock +19% · XLV -10%
matured Jul 15, 25
Canaccord Genuity ↗
May 8, 24
▲ Buy · 🎯$272
Price at call : $209.4 — upside +30%
Today : $321 — upside -15%
Expected +30% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+42.0%
stock +42% · XLV -7%
matured May 8, 25
Piper Sandler ↗
May 8, 24
▲ Overweight · 🎯$260
Price at call : $209.4 — upside +24%
Today : $321 — upside -19%
Expected +24% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+42.0%
stock +42% · XLV -7%
matured May 8, 25
Piper Sandler ↗
Apr 3, 24
▲ Overweight · 🎯$290
Price at call : $215.46 — upside +35%
Today : $321 — upside -10%
Expected +35% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+21.7%
stock +22% · XLV -5%
matured Apr 3, 25
Truist Securities ↗
Mar 22, 24
▲ Buy · 🎯$280
Price at call : $224.74 — upside +25%
Today : $321 — upside -13%
Expected +25% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+27.4%
stock +27% · XLV +1%
matured Mar 22, 25
Piper Sandler ↗
Feb 23, 24
▲ Overweight · 🎯$290
Price at call : $231.26 — upside +25%
Today : $321 — upside -10%
Expected +25% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+24.4%
stock +24% · XLV +0%
matured Feb 22, 25
Canaccord Genuity ↗
Feb 23, 24
▲ Buy · 🎯$284
Price at call : $231.26 — upside +23%
Today : $321 — upside -12%
Expected +23% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+24.4%
stock +24% · XLV +0%
matured Feb 22, 25
Truist Securities ↗
Feb 23, 24
▲ Buy · 🎯$290
Price at call : $238.37 — upside +22%
Today : $321 — upside -10%
Expected +22% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+20.7%
stock +21% · XLV -0%
matured Feb 22, 25
Truist Securities ↗
Dec 22, 23
▲ Buy · 🎯$295
Price at call : $260.14 — upside +13%
Today : $321 — upside -8%
Expected +13% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-7.5%
stock -8% · XLV +3%
matured Dec 21, 24
Piper Sandler ↗
Nov 3, 23
▲ Overweight · 🎯$250
Price at call : $198.69 — upside +26%
Today : $321 — upside -22%
Expected +26% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+15.5%
stock +16% · XLV +14%
matured Nov 2, 24
Piper Sandler ↗
Sep 19, 23
▲ Overweight · 🎯$335
Price at call : $262.43 — upside +28%
Today : $321 — upside +4%
Expected +28% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-23.5%
stock -23% · XLV +19%
matured Sep 18, 24
Canaccord Genuity ↗
Aug 2, 23
▲ Buy · 🎯$322
Price at call : $255.28 — upside +26%
Today : $321 — upside +0%
Expected +26% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-31.3%
stock -31% · XLV +14%
matured Aug 1, 24
Wells Fargo ↗
Aug 2, 23
▲ Overweight · 🎯$337
Price at call : $269.46 — upside +25%
Today : $321 — upside +5%
Expected +25% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
-36.4%
stock -36% · XLV +13%
matured Aug 1, 24
▲ Buy · 🎯$328
Price at call : $321.83 — upside +2%
Today : $321 — upside +2%
Expected +2% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-40.7%
stock -41% · XLV +11%
matured Jun 4, 24
Piper Sandler ↗
May 24, 23
▲ Overweight · 🎯$335
Price at call : $304.9 — upside +10%
Today : $321 — upside +4%
Expected +10% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-36.5%
stock -36% · XLV +13%
matured May 23, 24
▲ Buy · 🎯$312
Price at call : $301.88 — upside +3%
Today : $321 — upside -3%
Expected +3% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
-30.9%
stock -31% · XLV +6%
matured May 2, 24
Piper Sandler ↗
May 3, 23
▲ Overweight · 🎯$300
Price at call : $301.04 — upside -0%
Today : $321 — upside -7%
Expected -0% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-31.6%
stock -32% · XLV +5%
matured May 2, 24
Wells Fargo ↗
May 3, 23
▲ Overweight · 🎯$320
Price at call : $301.04 — upside +6%
Today : $321 — upside -0%
Expected +6% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
-31.6%
stock -32% · XLV +5%
matured May 2, 24
Canaccord Genuity ↗
Feb 24, 23
▲ Buy · 🎯$286
Price at call : $264.82 — upside +8%
Today : $321 — upside -11%
Expected +8% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-12.7%
stock -13% · XLV +15%
matured Feb 24, 24
▲ Buy · 🎯$270
Price at call : $250 — upside +8%
Today : $321 — upside -16%
Expected +8% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+0.0%
stock +0% · XLV +7%
matured Jan 30, 24
Wells Fargo ↗
Dec 12, 22
▲ Overweight · 🎯$255
Price at call : $225.32 — upside +13%
Today : $321 — upside -21%
Expected +13% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+6.7%
stock +7% · XLV -3%
matured Dec 12, 23
▲ Buy · 🎯$240
Price at call : $216.01 — upside +11%
Today : $321 — upside -25%
Expected +11% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+2.7%
stock +3% · XLV -4%
matured Dec 5, 23
Wells Fargo ↗
Nov 4, 22
▲ Overweight · 🎯$225
Price at call : $178.16 — upside +26%
Today : $321 — upside -30%
Expected +26% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+11.5%
stock +12% · XLV -3%
matured Nov 4, 23
▲ Buy · 🎯$239
Price at call : $194.45 — upside +23%
Today : $321 — upside -26%
Expected +23% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+35.1%
stock +35% · XLV +4%
matured Sep 19, 23
Canaccord Genuity ↗
Aug 5, 22
▲ Buy · 🎯$189
Price at call : $169.1 — upside +12%
Today : $321 — upside -41%
Expected +12% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+49.4%
stock +49% · XLV +2%
matured Aug 5, 23
▲ Buy · 🎯$213
Price at call : $124.71 — upside +71%
Today : $321 — upside -34%
Expected +71% · Actual +142% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 51.2% · +9.4% (41 calls)
+142.5%
stock +142% · XLV +2%
matured Jul 18, 23
Wells Fargo ↗
May 4, 22
▲ Overweight · 🎯$265
Price at call : $170.88 — upside +55%
Today : $321 — upside -17%
Expected +55% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+76.7%
stock +77% · XLV -0%
matured May 4, 23
Wells Fargo ↗
Feb 24, 21
▲ Overweight · 🎯$310
Price at call : $284.7 — upside +9%
Today : $321 — upside -3%
Expected +9% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
-21.7%
stock -22% · XLV +15%
matured Feb 24, 22
Canaccord Genuity ↗
Dec 16, 20
▲ Buy · 🎯$204
Price at call : $180.54 — upside +13%
Today : $321 — upside -36%
Expected +13% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 83% (12 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+40.3%
stock +40% · XLV +22%
matured Dec 16, 21
Wells Fargo ↗
Oct 29, 20
▲ Overweight · 🎯$265
Price at call : $261.03 — upside +2%
Today : $321 — upside -17%
Expected +2% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+7.1%
stock +7% · XLV +31%
matured Oct 29, 21
Wells Fargo ↗
Mar 30, 20
▲ Overweight · 🎯$180
Price at call : $161.33 — upside +12%
Today : $321 — upside -44%
Expected +12% · Actual +68% · Reason (≥ +15%) : ✓ Yes
🎯 on PEN : 75% (12 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+67.7%
stock +68% · XLV +32%
matured Mar 30, 21
Frequently asked questions
Should I buy Penumbra, Inc. stock?
This isn't buy advice. For Penumbra, Inc., the analyst consensus is "Hold", with an average price target of $350 (+9% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Penumbra, Inc.). We show the numbers — you decide.
Is it too late to buy Penumbra, Inc.? How high can it go?
The most bullish analyst target on Penumbra, Inc. is $374 (+17% above today's price); the average is $350. That's the upside they see. Check how reliable those analysts have actually been on Penumbra, Inc. on our site before trusting it.
Is Penumbra, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 15 analysts have a real record on Penumbra, Inc., the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
What has Penumbra, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: PEN performance & returns.
What is the best month to buy PEN?
The 12 months ranked by the stock's past returns: best & worst month to buy PEN.
Are insiders buying PEN stock?
Executives' and large holders' buys and sells, decoded: insider buying on PEN.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX